Finance

France has had no request for investment approval in biotech Abivax - official

Published by Global Banking & Finance Review

Posted on January 12, 2026

1 min read

· Last updated: January 20, 2026

Add as preferred source on Google
Russian bomb factory acquiring Siemens technology amid sanctions - Global Banking & Finance Review
Image illustrating the Biysk Oleum Factory's acquisition of Siemens equipment via intermediaries, highlighting the circumvention of Western sanctions. This reflects ongoing military production efforts in Russia.
Global Banking & Finance Awards 2026 — Call for Entries

PARIS, Jan 12 (Reuters) - France's finance ministry has received no request seeking investment approval in Abivax and has had no contact with Eli Lilly, a ministry official said on Monday, following

France's Finance Ministry Confirms No Investment Requests for Abivax

Investment Approval Status for Abivax

PARIS, Jan 12 (Reuters) - France's finance ministry has received no request seeking investment approval in Abivax and has had no contact with Eli Lilly, a ministry official said on Monday, following media reports that the U.S. pharma giant was still interested in buying the French biotech firm.

Official Statement from Finance Ministry

(Reporting by Mathieu Rosemain, writing by Louise Rasmussen, editing by Benoit Van Overstraeten)

Key Takeaways

  • France's finance ministry has not received any investment requests for Abivax.
  • There has been no contact with Eli Lilly regarding Abivax.
  • Media reports suggested Eli Lilly's interest in Abivax.
  • The finance ministry provided an official statement.
  • The situation remains unchanged as of now.

Frequently Asked Questions

What is biotech?
Biotech, or biotechnology, refers to the use of living organisms or their systems to develop products, often in the fields of medicine, agriculture, and environmental science.
What is Eli Lilly?
Eli Lilly and Company is a global pharmaceutical company known for its innovative medicines and commitment to improving patient outcomes through research and development.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category